BlackRock Investment Management’s NanoViricides NNVC Stock Holding History

BlackRock Investment Management’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$8K	Hold	363	–	–	﹤0.01%	3663
2016 Q3	$12K	Hold	363	–	–	﹤0.01%	3529
2016 Q2	$12K	Buy	363 +31	+9%	+$1.13K	﹤0.01%	3560
2016 Q1	$15K	Sell	332 -43	-11%	-$1.67K	﹤0.01%	3463
2015 Q4	$9K	Buy	375 +37	+11%	+$886	﹤0.01%	3716
2015 Q3	$8K	Hold	338	–	–	﹤0.01%	3776
2015 Q2	$12K	Sell	338 -5,963	-95%	-$227K	﹤0.01%	3644
2015 Q1	$284K	Buy	6,301 +101	+2%	+$5.38K	﹤0.01%	3143
2014 Q4	$337K	Buy	6,200 +376	+6%	+$24.9K	﹤0.01%	3156
2014 Q3	$349K	Buy	5,824 +161	+3%	+$12.6K	﹤0.01%	3131
2014 Q2	$479K	Buy	+5,663	New	+$402K	﹤0.01%	3062

Other funds holding NNVC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

SCA

STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.57B AUM 26.96% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

BlackRock Investment Management's NNVC Position: Q4 2016 in Review

BlackRock Investment Management held its NanoViricides (NNVC) position steady in Q4 2016 at 363 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #3663.

BlackRock Investment Management first reported a position in NNVC in Q2 2014 and has held it in 11 quarters since. The position peaked at $479K in Q2 2014. 44 funds tracked by Wall St. Rank hold NNVC as of Q4 2016.

BlackRock Investment Management held 363 shares of NanoViricides worth $8K as of Q4 2016.
BlackRock Investment Management left its NanoViricides share count unchanged in Q4 2016.
NanoViricides made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3663 holding.
BlackRock Investment Management first reported a position in NanoViricides in Q2 2014 and has held it in 11 quarters since.
BlackRock Investment Management's NanoViricides position peaked at $479K in Q2 2014.
44 funds tracked by Wall St. Rank held NanoViricides as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.